NVO logo

Novo Nordisk A/S (NVO) Long term debt

Annual long term debt:

$12.45B+$9.41B(+309.34%)
December 31, 2024

Summary

  • As of today (September 12, 2025), NVO annual long term debt is $12.45 billion, with the most recent change of +$9.41 billion (+309.34%) on December 31, 2024.
  • During the last 3 years, NVO annual long term debt has risen by +$10.47 billion (+528.34%).
  • NVO annual long term debt is now at all-time high.

Performance

NVO Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Quarterly long term debt:

$13.74B-$208.16M(-1.49%)
June 1, 2025

Summary

  • As of today (September 12, 2025), NVO quarterly long term debt is $13.74 billion, with the most recent change of -$208.16 million (-1.49%) on June 1, 2025.
  • Over the past year, NVO quarterly long term debt has increased by +$6.32 billion (+85.20%).
  • NVO quarterly long term debt is now -1.49% below its all-time high of $13.94 billion, reached on March 31, 2025.

Performance

NVO Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

NVO Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+309.3%+85.2%
3 y3 years+528.3%+304.1%
5 y5 years+2654.8%+3232.8%

NVO Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+528.3%-1.5%+465.9%
5 y5-yearat high+2654.8%-1.5%+3232.8%
alltimeall timeat high>+9999.0%-1.5%>+9999.0%

NVO Long term debt History

DateAnnualQuarterly
Jun 2025
-
$13.74B(-1.5%)
Mar 2025
-
$13.94B(+12.0%)
Dec 2024
$12.45B(+309.3%)
$12.45B(+61.7%)
Sep 2024
-
$7.70B(+3.9%)
Jun 2024
-
$7.42B(+205.6%)
Mar 2024
-
$2.43B(-20.2%)
Dec 2023
$3.04B(-12.8%)
$3.04B(+7.5%)
Sep 2023
-
$2.83B(-0.6%)
Jun 2023
-
$2.84B(-19.6%)
Mar 2023
-
$3.54B(+1.4%)
Dec 2022
$3.49B(+76.1%)
$3.49B(+9.7%)
Sep 2022
-
$3.18B(-6.4%)
Jun 2022
-
$3.40B(-5.7%)
Mar 2022
-
$3.60B(+81.8%)
Dec 2021
$1.98B(+316.1%)
$1.98B(+2.6%)
Sep 2021
-
$1.93B(-2.8%)
Jun 2021
-
$1.99B(+344.1%)
Mar 2021
-
$447.54M(-6.0%)
Dec 2020
$476.21M(+5.4%)
$476.21M(+14.7%)
Sep 2020
-
$415.27M(+0.8%)
Jun 2020
-
$412.15M(-2.2%)
Mar 2020
-
$421.42M(-6.8%)
Dec 2019
$452.01M(>+9900.0%)
$452.01M(+5.8%)
Sep 2019
-
$427.39M(-5.9%)
Jun 2019
-
$454.23M(-5.7%)
Mar 2019
-
$481.90M(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
Dec 2017
$0.00(0.0%)
$0.00(0.0%)
Sep 2017
-
$0.00(0.0%)
Jun 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2012
-
$86.81M(+1.3%)
Jun 2012
-
$85.69M(-6.3%)
Mar 2012
-
$91.47M(+4.3%)
Dec 2011
$87.68M
$87.68M(-3.1%)
DateAnnualQuarterly
Sep 2011
-
$90.51M(-7.6%)
Jun 2011
-
$97.97M(+2.1%)
Mar 2011
-
$95.93M(+5.7%)
Dec 2010
$90.73M(-51.5%)
$90.73M(-50.2%)
Sep 2010
-
$182.28M(+8.9%)
Jun 2010
-
$167.40M(-4.9%)
Mar 2010
-
$175.94M(-5.9%)
Dec 2009
$187.03M(+2.2%)
$187.03M(-1.1%)
Sep 2009
-
$189.08M(+2.5%)
Jun 2009
-
$184.40M(+2.4%)
Mar 2009
-
$180.04M(-1.6%)
Dec 2008
$183.02M(-2.9%)
$183.02M(-0.2%)
Sep 2008
-
$183.37M(-6.7%)
Jun 2008
-
$196.47M(-0.5%)
Mar 2008
-
$197.40M(+4.8%)
Dec 2007
$188.43M(-9.3%)
$188.43M(-12.8%)
Sep 2007
-
$215.97M(+2.4%)
Jun 2007
-
$210.88M(+0.7%)
Mar 2007
-
$209.38M(+0.8%)
Dec 2006
$207.67M(+5.2%)
$207.67M(+3.3%)
Sep 2006
-
$201.12M(-0.4%)
Jun 2006
-
$201.93M(+2.2%)
Mar 2006
-
$197.52M(+0.1%)
Dec 2005
$197.36M(-9.1%)
$197.36M(-4.0%)
Sep 2005
-
$205.50M(-0.6%)
Jun 2005
-
$206.65M(-4.9%)
Mar 2005
-
$217.37M(+0.1%)
Dec 2004
$217.08M(+70.2%)
$217.08M(+74.4%)
Sep 2004
-
$124.51M(+6.2%)
Jun 2004
-
$117.20M(-8.0%)
Mar 2004
-
$127.43M(-0.1%)
Dec 2003
$127.56M(+9.6%)
$127.56M(+9.6%)
Dec 2002
$116.41M(+12.6%)
$116.41M(>+9900.0%)
Jun 2002
-
$0.00(-100.0%)
Dec 2001
$103.35M(-13.5%)
$103.35M(-12.4%)
Dec 2000
$119.50M(-76.2%)
$118.01M(-13.0%)
Dec 1999
$502.67M(+74.3%)
$135.70M(-52.8%)
Dec 1998
$288.32M(+12.3%)
$287.31M(+11.1%)
Dec 1997
$256.74M(+60.4%)
$258.61M(+62.5%)
Dec 1996
$160.03M(-32.9%)
$159.17M(-33.1%)
Dec 1995
$238.54M(-53.3%)
$238.01M(-53.4%)
Dec 1994
$510.89M(+4.0%)
$510.82M(+3.4%)
Dec 1993
$491.32M(+18.8%)
$493.92M(+19.4%)
Dec 1992
$413.52M(+42.7%)
$413.52M(+42.7%)
Dec 1991
$289.77M(+46.8%)
$289.81M(+46.9%)
Dec 1990
$197.36M(-16.8%)
$197.30M(-16.5%)
Dec 1989
$237.34M(+94.5%)
$236.42M(+93.4%)
Dec 1988
$122.01M(-15.0%)
$122.26M(-15.2%)
Dec 1987
$143.53M(+14.7%)
$144.25M(+15.2%)
Dec 1986
$125.12M(+52.3%)
$125.17M(+52.4%)
Dec 1985
$82.18M(+63.1%)
$82.15M(+62.7%)
Dec 1984
$50.40M(+12.7%)
$50.48M
Dec 1983
$44.71M(-15.7%)
-
Dec 1982
$53.01M(-18.1%)
-
Dec 1981
$64.74M(-6.8%)
-
Dec 1980
$69.45M
-

FAQ

  • What is Novo Nordisk A/S annual long term debt?
  • What is the all time high annual long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual long term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly long term debt?
  • What is the all time high quarterly long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly long term debt year-on-year change?

What is Novo Nordisk A/S annual long term debt?

The current annual long term debt of NVO is $12.45B

What is the all time high annual long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual long term debt is $12.45B

What is Novo Nordisk A/S annual long term debt year-on-year change?

Over the past year, NVO annual long term debt has changed by +$9.41B (+309.34%)

What is Novo Nordisk A/S quarterly long term debt?

The current quarterly long term debt of NVO is $13.74B

What is the all time high quarterly long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly long term debt is $13.94B

What is Novo Nordisk A/S quarterly long term debt year-on-year change?

Over the past year, NVO quarterly long term debt has changed by +$6.32B (+85.20%)
On this page